Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Astaxanthin is a red fat-soluble xanthophyll carotenoid pigment found naturally in microalgae (notably Haematococcus pluvialis), yeast, and marine animals such as krill and salmon. It is structurally similar to other carotenoids but distinguished by the presence of both hydroxyl and keto groups at each end of its polyene chain. This unique structure confers potent antioxidant properties—significantly stronger than vitamin E or β-carotene—by allowing it to align within cell membranes and protect against oxidative stress. Astaxanthin acts as an anti-inflammatory agent by inhibiting NF-kB signaling pathways and reducing pro-inflammatory cytokines. It has been studied for potential benefits in cardiovascular health, metabolic syndrome (including diabetes), skin protection from UV damage, anti-aging effects, improved blood flow in hypertension models, chemoprevention via upregulation of connexin 43 expression in vitro, and general cellular protection[1][6][8].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on astaxanthin.